Cargando…
Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
Approximately two-thirds of US children and adolescents have either obesity or overweight status, with almost 24% of adolescents (ages 12–19 years) afflicted with severe obesity, defined as >1.2 × the 95th BMI percentile for age/gender. Despite the increasing disproportionate rise in severe or ex...
Autores principales: | Srivastava, Gitanjali, O’Hara, Valerie, Browne, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406487/ https://www.ncbi.nlm.nih.gov/pubmed/30720744 http://dx.doi.org/10.3390/children6020022 |
Ejemplares similares
-
Alexithymia in obese adolescents is associated with severe obesity and binge eating behavior
por: Fanton, Susane, et al.
Publicado: (2021) -
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova, Anna I, et al.
Publicado: (2016) -
The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
por: Ágh, Tamás, et al.
Publicado: (2016) -
Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
por: Griffiths, Kristi R., et al.
Publicado: (2021) -
Are obesity risk genes associated with binge eating in adolescence?
por: Micali, Nadia, et al.
Publicado: (2015)